Pfizer Inc. has announced that Patrizia Cavazzoni, M.D. will rejoin the company as Chief Medical Officer, Executive Vice ...
On track to provide clinical data from the 12 mg dose cohort from the Phase 1b PIONEER trial of pociredir in SCD in mid-2025 and the 20 mg dose ...
On track to provide clinical data from the 12 mg dose cohort from the Phase 1b PIONEER trial of pociredir in SCD in mid-2025 ...
The problem for Sanofi is that J&J has just claimed FDA approval for a new, subcutaneous formulation of its drug – called Darzalex Faspro – that can be administered in a matter of minutes.
Teva Pharmaceuticals (TEVA) and Medincell (MEDCL) announced that the supplemental New Drug Application sNDA for UZEDY extended-release ...
The US Food and Drug Administration (FDA) has accepted for priority review a new supplemental Biologics License Application ...
The US Food and Drug Administration (FDA) has lifted the clinical hold on ENTR-601-44 and provided authorization to initiate ELEVATE-44-102, a Phase Ib multiple ascending dose (MAD) clinical study of ...
Lowering the price of the 2.5 mg dose vial to $349 per month. Lowering the price of the 5 mg dose vial to $499 per month.
The Federal Communications Commission (FCC) under new chair Brendan Carr has issued an enforcement advisory addressing complaints that radio ...
Sanofi is reorganising its business units from seven to five in a bid to streamline its operations and ensure the success of its ambitious product launch plans. The revamp is the first major ...
Discover the latest industry insights at the 2025 Annual Meeting through engaging educational and product-focused sessions. These presentations give exhibiting companies a platform to unveil ...
An Illinois jury sided with Boehringer Ingelheim in a Zantac cancer lawsuit. Learn about the legal angles, previous trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results